Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...